You just read:

Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society

News provided by

Amira Pharmaceuticals, Inc.

11 May, 2011, 16:00 BST